CN113646009A - 用作铁(iii)mri造影剂且含阴离子侧基和辅助基团的化合物 - Google Patents

用作铁(iii)mri造影剂且含阴离子侧基和辅助基团的化合物 Download PDF

Info

Publication number
CN113646009A
CN113646009A CN201980089289.XA CN201980089289A CN113646009A CN 113646009 A CN113646009 A CN 113646009A CN 201980089289 A CN201980089289 A CN 201980089289A CN 113646009 A CN113646009 A CN 113646009A
Authority
CN
China
Prior art keywords
substituted
group
macrocyclic
unsubstituted
iii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980089289.XA
Other languages
English (en)
Chinese (zh)
Inventor
J·R·莫罗
林醉嬬
D·阿斯克
E·M·斯尼德
E·A·卡斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Research Foundation of the State University of New York
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of the State University of New York filed Critical Research Foundation of the State University of New York
Publication of CN113646009A publication Critical patent/CN113646009A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F19/00—Metal compounds according to more than one of main groups C07F1/00 - C07F17/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN201980089289.XA 2018-11-16 2019-11-18 用作铁(iii)mri造影剂且含阴离子侧基和辅助基团的化合物 Pending CN113646009A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862768823P 2018-11-16 2018-11-16
US62/768,823 2018-11-16
PCT/US2019/062077 WO2020102820A1 (en) 2018-11-16 2019-11-18 Compounds for use as iron (iii) mri contrast agents containing anionic pendents and ancillary groups

Publications (1)

Publication Number Publication Date
CN113646009A true CN113646009A (zh) 2021-11-12

Family

ID=70730921

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980089289.XA Pending CN113646009A (zh) 2018-11-16 2019-11-18 用作铁(iii)mri造影剂且含阴离子侧基和辅助基团的化合物

Country Status (7)

Country Link
US (1) US11344635B2 (https=)
EP (1) EP3880257A4 (https=)
JP (2) JP7582942B2 (https=)
KR (1) KR20210114932A (https=)
CN (1) CN113646009A (https=)
AU (1) AU2019381793B2 (https=)
WO (1) WO2020102820A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019381793B2 (en) * 2018-11-16 2025-02-27 The Research Foundation For The State University Of New York Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups
US20240228524A1 (en) * 2021-03-20 2024-07-11 The Research Foundation For The State University Of New York Iron(iii) macrocyclic complexes with mixed hyroxyl pendants as mri contrast agents
WO2024097160A1 (en) * 2022-10-31 2024-05-10 Yale University Transition metal complexes for mri applications and methods of use
CN121698848A (zh) * 2026-02-09 2026-03-20 浙江大学衢州研究院 一种具有三氮杂环壬烷大环骨架的铁配合物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1189105A (zh) * 1995-06-26 1998-07-29 康凯有限公司 对第一过渡系元素具有螯合亲和力和选择性的化合物及它们在医学治疗和诊断中的用途
WO2015038943A1 (en) * 2013-09-12 2015-03-19 The Research Foundation For The State University Of New York University At Buffalo Macrocycles, cobalt and iron complexes of same, and methods of making and using same
CN110944676A (zh) * 2017-05-19 2020-03-31 纽约州立大学研究基金会 用作铁(iii)mri造影剂的化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2091251T3 (es) * 1989-11-27 1996-11-01 Concat Ltd Perfeccionamiento de la imagen en la mri del hueso y del tejido emparentado utilizando complejos de cationes paramagneticos y ligandos polifosfonato.
US5236695A (en) 1989-11-27 1993-08-17 Concat, Ltd. MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands
US5409689A (en) 1993-08-13 1995-04-25 Concat, Ltd. MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms
US6264966B1 (en) 2000-02-22 2001-07-24 Concat, Ltd. Compounds with chelation affinity and selectivity for first transition elements and their use in cosmetics and personal care products, inhibition of metalloenzymes, and inhibition of reperfusion injury
US20050112066A1 (en) 2003-11-26 2005-05-26 Concat Lp, A California Limited Partnership Complexes of cyclic polyaza chelators with cations of alkaline earth metals for enhanced biological activity
WO2012027727A2 (en) * 2010-08-26 2012-03-01 Kunyuan Cui Lipomacrocycles and uses thereof
WO2013060793A1 (en) 2011-10-25 2013-05-02 Technische Universität München Bifunctional ligands for radiometals
CN104119402B (zh) 2014-08-01 2016-08-24 南京大学 具有单分子磁行为和荧光精细结构的有机膦酸镝配合物
AU2019381793B2 (en) * 2018-11-16 2025-02-27 The Research Foundation For The State University Of New York Compounds for use as iron (III) MRI contrast agents containing anionic pendents and ancillary groups

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1189105A (zh) * 1995-06-26 1998-07-29 康凯有限公司 对第一过渡系元素具有螯合亲和力和选择性的化合物及它们在医学治疗和诊断中的用途
WO2015038943A1 (en) * 2013-09-12 2015-03-19 The Research Foundation For The State University Of New York University At Buffalo Macrocycles, cobalt and iron complexes of same, and methods of making and using same
CN110944676A (zh) * 2017-05-19 2020-03-31 纽约州立大学研究基金会 用作铁(iii)mri造影剂的化合物

Also Published As

Publication number Publication date
JP2022507519A (ja) 2022-01-18
AU2019381793A1 (en) 2021-06-24
WO2020102820A1 (en) 2020-05-22
AU2019381793B2 (en) 2025-02-27
JP7582942B2 (ja) 2024-11-13
JP2024178308A (ja) 2024-12-24
KR20210114932A (ko) 2021-09-24
US20210260222A1 (en) 2021-08-26
EP3880257A4 (en) 2022-07-27
US11344635B2 (en) 2022-05-31
EP3880257A1 (en) 2021-09-22

Similar Documents

Publication Publication Date Title
US12534487B2 (en) Compounds for use as iron(III) MRI contrast agents
JP2024178308A (ja) アニオン性ペンダントおよび補助基を含む、鉄（ｉｉｉ）ｍｒｉ造影剤として使用するための化合物
Asik et al. Dinuclear Fe (III) hydroxypropyl-appended macrocyclic complexes as MRI probes
Phukan et al. A new bis (aquated) high relaxivity Mn (II) complex as an alternative to Gd (III)-based MRI contrast agent
KR101469900B1 (ko) Do3a-디아미노바이페닐 화합물 및 이를 리간드로 포함하는 가돌리늄 착물
Forgacs et al. Mono-, Bi-, and trinuclear bis-hydrated Mn2+ complexes as potential MRI contrast agents
US10960088B2 (en) Macrocycles, cobalt and iron complexes of same, and methods of making and using same
Uzal-Varela et al. Thermodynamic stability of Mn (II) complexes with aminocarboxylate ligands analyzed using structural descriptors
Tei et al. Mn (II) complexes of novel hexadentate AAZTA-like chelators: a solution thermodynamics and relaxometric study
EP1469890A1 (en) Responsive paramagnetic mri contrast agents
US9302019B2 (en) Fe(II) sequestering agents and uses thereof
Pražáková et al. A seven-coordinate Mn (ii) complex with a pyridine-based 15-membered macrocyclic ligand containing one acetate pendant arm: structure, stability and relaxation properties
US20240228524A1 (en) Iron(iii) macrocyclic complexes with mixed hyroxyl pendants as mri contrast agents
La Cava et al. Synthesis, characterization, and biodistribution of a dinuclear gadolinium complex with improved properties as a blood pool MRI agent
Pushparaj et al. Trinuclear Gd (III) metal complex with amide core display remarkable enhancement in relaxivity
Kras A Comparison of Oxygen-Donor Pendant Groups for Iron (III) Macrocyclic T1 MRI Probes
Prazakova et al. Expanding the Family of Monosubstituted 15-Membered Pyridine-Based Macrocyclic Ligands for Mn (II) Complexation in the Context of MRI
Cineus Phenolate-Based Fe (III) Complexes as MRI Probes
Garcia Studies on the physicochemical properties of europium cryptates: Implications to contrast agents for magnetic resonance imaging
CN117729943A (zh) 具有混合羟基侧基的铁(iii)大环配合物作为mri造影剂
Allen Developing New Ligand Platforms for MRI Contrast Agents
Major Coordination complexes for the development of zinc (II)-activated MR imaging probes

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20211112

WD01 Invention patent application deemed withdrawn after publication